J Korean Ophthalmol Soc.  2006 Aug;47(8):1238-1243.

The Risk Factors for Severe Thyroid-Associated Orbitopathy

Affiliations
  • 1Department of Ophthalmology, Kangdong Sacred Heart Hospital, Hallym University, College of Medicine, Seoul, Korea. feeloph@naver.com
  • 2Department of Ophthalmology, New York Presbyterian Hospital, Columbia University, College of Physicians and Surgeons, New York, U.S.A.

Abstract

PURPOSE: To determine risk factors for severe Thyroid-Associated Orbitopathy (TAO).
METHODS
We retrospectively studied the clinical data of 385 patients of the New York City area diagnosed with TAO from January 1990 to December 2000. We reviewed clinical characteristics and tried to identify several risk factors. The statistical analysis was applied to the collected data.
RESULTS
Men more frequently had proptosis, restrictive myopathy, and optic neuropathy than women. Patients older than 50 years presented more frequently with proptosis, restrictive myopathy, and optic neuropathy than younger than 50 years. Patients with a family history of thyroid disease had similar clinical characteristics compare to those without family history. Smokers more often had proptosis, restrictive myopathy, and compressive optic neuropathy than nonsmokers. Patients who had received radioactive iodine (RAI) treatment were older, and were more frequently smokers. If patients were smokers and treated with radioactive iodine treatment, they were more likely to have proptosis, restrictive myopathy, and compressive optic neuropathy than if not treated with radioactive iodine. However, the RAI treatment did not seem to be associated with severe characteristics of TAO in non-smokers.
CONCLUSIONS
The risk factors for severe TAO are: male, age older than 50, smoking, treated with RAI in smokers.

Keyword

Risk factor; Thyroid-associated orbitopathy (TAO); New york city

MeSH Terms

Exophthalmos
Female
Humans
Iodine
Male
Muscular Diseases
Optic Nerve Diseases
Retrospective Studies
Risk Factors*
Smoke
Smoking
Thyroid Diseases
Troleandomycin
Iodine
Smoke
Troleandomycin
Full Text Links
  • JKOS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr